How is brucellosis transmitted from animals to humans. What are the main risk factors for contracting brucellosis. Who is most at risk of getting infected with Brucella bacteria. How can brucellosis be prevented and controlled effectively.

What is Brucellosis and How Does it Spread?

Brucellosis is a bacterial zoonotic disease caused by various species of Brucella bacteria. These bacteria primarily infect animals like cattle, swine, goats, sheep, and dogs. Humans typically contract brucellosis through direct contact with infected animals or by consuming contaminated animal products.

The main ways brucellosis spreads to humans include:

• Consuming unpasteurized dairy products, especially milk and cheese from infected goats or sheep
• Direct contact with infected animals’ blood, placenta, fetuses or uterine secretions
• Inhaling airborne bacteria in settings like laboratories or slaughterhouses

Person-to-person transmission of brucellosis is extremely rare. The disease is found globally and is a reportable condition in most countries due to its public health impact.

Who is at Highest Risk for Contracting Brucellosis?

While brucellosis can affect people of all ages and genders, certain groups face an elevated risk of infection:

1. Livestock farmers and ranchers
2. Veterinarians
3. Slaughterhouse workers
4. Dairy industry workers
5. Laboratory personnel handling Brucella cultures
6. Consumers of unpasteurized dairy products

Those who work directly with animals or animal products have the highest occupational risk. In the general population, consuming raw milk or fresh cheeses made from unpasteurized milk is the primary source of infection.

What Are the Symptoms and Health Impacts of Brucellosis?

Brucellosis typically causes flu-like symptoms that can be acute or persistent. Common signs and symptoms include:

• Fever
• Sweats
• Fatigue
• Weakness
• Headache
• Muscle and joint pain
• Weight loss

In severe cases, brucellosis can lead to complications affecting various organ systems. Chronic brucellosis can cause long-term health issues if left untreated.

How quickly do brucellosis symptoms appear after exposure?

The incubation period for brucellosis typically ranges from 5 to 60 days, with most people developing symptoms within 2-4 weeks of exposure. However, some cases may not show symptoms for several months after the initial infection.

Which Brucella Species Pose the Greatest Threat to Humans?

While several Brucella species can infect humans, Brucella melitensis is considered the most prevalent and virulent. This is partly due to:

• Its widespread presence in sheep and goat populations
• Difficulties in vaccinating free-ranging small ruminants
• The popularity of sheep and goat milk products in many regions

Other important species include B. abortus (cattle), B. suis (pigs), and B. canis (dogs). The specific Brucella species involved can influence the severity and treatment of human infections.

How Can Brucellosis Be Prevented and Controlled?

Preventing brucellosis requires a multi-faceted approach targeting both animal and human health. Key prevention strategies include:

1. Pasteurization of all dairy products
2. Vaccination of livestock
3. Regular testing and culling of infected animals
4. Proper hygiene and protective equipment for at-risk workers
5. Public education on the risks of consuming raw dairy products
6. Improved sanitation in animal husbandry practices

Effective control of brucellosis in animal populations is crucial for reducing human cases. This often requires coordinated efforts between public health, veterinary, and agricultural sectors.

Is there a vaccine available for human brucellosis?

Currently, there is no approved vaccine for human brucellosis. Prevention relies primarily on controlling the disease in animals and avoiding exposure to contaminated animal products. Research into potential human vaccines is ongoing, but none have yet proven safe and effective for widespread use.

What Role Does Surveillance Play in Brucellosis Control?

Surveillance is a critical component of brucellosis prevention and control efforts. Effective surveillance systems help to:

• Detect outbreaks early
• Monitor disease trends
• Identify high-risk areas or populations
• Evaluate the effectiveness of control measures
• Guide resource allocation for prevention programs

Both animal and human health surveillance are important for a comprehensive approach to brucellosis control. This often involves collaboration between multiple agencies and sectors.

How is brucellosis surveillance conducted?

Brucellosis surveillance typically involves a combination of passive and active methods:

1. Passive surveillance: Monitoring of reported cases from healthcare providers and laboratories
2. Active surveillance: Targeted screening of high-risk groups or animals
3. Serological surveys: Testing blood samples for Brucella antibodies
4. Environmental sampling: Monitoring of milk and other animal products

Advanced molecular techniques, such as PCR and genotyping, are increasingly used to enhance surveillance capabilities and track the spread of specific Brucella strains.

What Challenges Exist in Controlling Brucellosis Globally?

Despite being a well-known zoonotic disease, brucellosis remains a significant public health challenge in many parts of the world. Some of the key obstacles to effective control include:

• Inadequate veterinary services in resource-limited settings
• Cultural practices favoring consumption of raw dairy products
• Limited diagnostic capabilities in some regions
• Difficulties in vaccinating free-ranging and nomadic livestock
• Economic impacts of culling infected animals
• Lack of awareness among at-risk populations

Addressing these challenges requires sustained commitment from governments, international organizations, and local communities. Integrated “One Health” approaches that consider human, animal, and environmental factors are increasingly recognized as essential for effective brucellosis control.

How does climate change impact brucellosis transmission?

Climate change may influence brucellosis transmission in several ways:

1. Altering the geographic distribution of host animals
2. Affecting the survival of Brucella bacteria in the environment
3. Changing human-animal interaction patterns due to resource scarcity
4. Impacting the effectiveness of control measures in changing ecosystems

Further research is needed to fully understand and mitigate the potential effects of climate change on brucellosis epidemiology.

How is Brucellosis Diagnosed and Treated in Humans?

Diagnosing brucellosis can be challenging due to its nonspecific symptoms. Proper diagnosis typically involves:

1. Clinical evaluation of symptoms
2. Patient history, including potential exposure risks
3. Blood cultures to isolate the bacteria
4. Serological tests to detect Brucella antibodies
5. PCR-based molecular diagnostics for rapid detection

Treatment usually consists of a combination of antibiotics taken for several weeks. The specific regimen may vary depending on the patient’s age, pregnancy status, and severity of infection.

What antibiotics are commonly used to treat brucellosis?

Standard treatment for uncomplicated brucellosis often includes:

• Doxycycline combined with rifampin for 6 weeks
• Doxycycline for 6 weeks plus streptomycin for 2-3 weeks
• Alternative regimens for pregnant women or children may include trimethoprim-sulfamethoxazole

Treatment duration and combinations may be adjusted based on clinical response and potential complications. Long-term follow-up is important to monitor for relapse.

What Economic Impact Does Brucellosis Have on Agriculture and Public Health?

Brucellosis imposes significant economic burdens on both the agricultural sector and healthcare systems. The costs associated with the disease include:

• Reduced livestock productivity
• Loss of animals due to culling or death
• Decreased milk and meat production
• Trade restrictions on animal products
• Human healthcare expenses for diagnosis and treatment
• Lost work productivity due to illness

In endemic areas, these economic impacts can be substantial. Effective control programs, while requiring initial investment, can yield significant long-term economic benefits by reducing both animal and human cases of brucellosis.

How is the economic impact of brucellosis measured?

Assessing the full economic impact of brucellosis involves considering multiple factors:

1. Direct costs: Medical expenses, livestock losses, control program implementation
2. Indirect costs: Lost productivity, trade restrictions, long-term health effects
3. Cost-benefit analysis of control measures
4. Disability-adjusted life years (DALYs) to quantify disease burden

Comprehensive economic evaluations help guide policy decisions and resource allocation for brucellosis control efforts.

What Research is Being Conducted to Improve Brucellosis Prevention and Treatment?

Ongoing research aims to enhance our understanding of brucellosis and develop more effective strategies for its prevention and control. Current areas of focus include:

• Development of improved vaccines for both animals and humans
• Novel diagnostic techniques for faster, more accurate detection
• Investigation of Brucella pathogenesis and host immune responses
• Identification of new antibiotic treatments and combination therapies
• Epidemiological studies to better understand transmission dynamics
• Evaluation of innovative control strategies in different settings

Advances in genomics, immunology, and biotechnology are providing new tools and approaches for brucellosis research. Collaborative international efforts are crucial for addressing this global health challenge.

What promising vaccine candidates are under investigation?

Several potential brucellosis vaccines are in various stages of research and development:

1. Subunit vaccines targeting specific Brucella antigens
2. DNA vaccines encoding protective bacterial proteins
3. Live attenuated strains with enhanced safety profiles
4. Nanoparticle-based delivery systems for improved immune responses

While progress has been made, significant challenges remain in developing a safe and effective human vaccine against brucellosis. Continued research and clinical trials are necessary to evaluate these candidates.

Brucellosis

Brucellosis

• All topics »
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• Resources »
  • Fact sheets
  • Facts in pictures
  • Multimedia
  • Publications
  • Questions & answers
  • Tools and toolkits
• Popular »
  • Air pollution
  • Coronavirus disease (COVID-19)
  • Hepatitis
  • Monkeypox
• All countries »
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• Regions »
  • Africa
  • Americas
  • South-East Asia
  • Europe
  • Eastern Mediterranean
  • Western Pacific
• WHO in countries »
  • Statistics
  • Cooperation strategies
  • Ukraine emergency
• All news »
  • News releases
  • Statements
  • Campaigns
  • Commentaries
  • Events
  • Feature stories
  • Speeches
  • Spotlights
  • Newsletters
  • Photo library
  • Media distribution list
• Headlines »
• Focus on »
  • Afghanistan crisis
  • COVID-19 pandemic
  • Northern Ethiopia crisis
  • Syria crisis
  • Ukraine emergency
  • Monkeypox outbreak
  • Greater Horn of Africa crisis
• Latest »
  • Disease Outbreak News
  • Travel advice
  • Situation reports
  • Weekly Epidemiological Record
• WHO in emergencies »
  • Surveillance
  • Research
  • Funding
  • Partners
  • Operations
  • Independent Oversight and Advisory Committee
  • WHO’s Health Emergency Appeal 2023
• Data at WHO »
  • Global Health Estimates
  • Health SDGs
  • Mortality Database
  • Data collections
• Dashboards »
  • COVID-19 Dashboard
  • Triple Billion Dashboard
  • Health Inequality Monitor
• Highlights »
  • Global Health Observatory
  • SCORE
  • Insights and visualizations
  • Data collection tools
• Reports »
  • World Health Statistics 2022
  • COVID excess deaths
  • DDI IN FOCUS: 2022
• About WHO »
  • People
  • Teams
  • Structure
  • Partnerships and collaboration
  • Collaborating centres
  • Networks, committees and advisory groups
  • Transformation
• Our Work »
  • General Programme of Work
  • WHO Academy
  • Activities
  • Initiatives
• Funding »
  • Investment case
  • WHO Foundation
• Accountability »
  • Audit
  • Programme Budget
  • Financial statements
  • Programme Budget Portal
  • Results Report
• Governance »
  • World Health Assembly
  • Executive Board
  • Election of Director-General
  • Governing Bodies website
  • Member States Portal
• Home/
• Newsroom/
• Fact sheets/
• Detail/
• Brucellosis

ILRI/Stevie Mann

Villager and calf share milk from cow in Rajasthan, India

©
Credits

 

“,”datePublished”:”2020-07-29T13:19:00. 0000000+00:00″,”image”:”https://www.who.int/images/default-source/departments/ntd-library/brucellosis/4189986967-f88b95458f-k.jpg?sfvrsn=8dda3d7e_16″,”publisher”:{“@type”:”Organization”,”name”:”World Health Organization: WHO”,”logo”:{“@type”:”ImageObject”,”url”:”https://www.who.int/Images/SchemaOrg/schemaOrgLogo.jpg”,”width”:250,”height”:60}},”dateModified”:”2020-07-29T13:19:00.0000000+00:00″,”mainEntityOfPage”:”https://www.who.int/news-room/fact-sheets/detail/brucellosis”,”@context”:”http://schema.org”,”@type”:”Article”};

Key facts

• Brucellosis is found globally and is a reportable disease in most countries
• The disease causes flu-like symptoms, including fever, weakness, malaise and weight loss
• Person-to-person transmission is rare
• Brucellosis is a bacterial disease caused by various Brucella species, which mainly infect cattle, swine, goats, sheep and dogs

Brucellosis is a bacterial disease caused by various Brucella species, which mainly infect cattle, swine, goats, sheep and dogs. Humans generally acquire the disease through direct contact with infected animals, by eating or drinking contaminated animal products or by inhaling airborne agents. Most cases are caused by ingesting unpasteurized milk or cheese from infected goats or sheep.

Brucellosis is one of the most widespread zoonoses transmitted by animals and in endemic areas, human brucellosis has serious public health consequences. Expansion of animal industries and urbanization, and the lack of hygienic measures in animal husbandry and in food handling, partly account for brucellosis remaining a public health hazard.

 

Who is at risk? 

Brucellosis is found globally and is a reportable disease in most countries. It affects people of all ages and both sexes. In the general population, most cases are caused by the consumption of raw milk or its derivatives such as fresh cheese. Most of these cases are from sheep and goat products.

The disease is also considered an occupational hazard for people who work in the livestock sector. People who work with animals and are in contact with blood, placenta, foetuses and uterine secretions have an increased risk of contracting the disease. This method of transmission primarily affects farmers, butchers, hunters, veterinarians and laboratory personnel.

Worldwide, Brucella melitensis is the most prevalent species causing human brucellosis, owing in part to difficulties in immunizing free-ranging goats and sheep.

Human-to-human transmission is very rare.

 

Prevention and control

Prevention of brucellosis is based on surveillance and the prevention of risk factors. The most effective prevention strategy is the elimination of infection in animals. Vaccination of cattle, goats and sheep is recommended in enzootic areas with high prevalence rates. Serological or other testing and culling can also be effective in areas with low prevalence. In countries where eradication in animals through vaccination or elimination of infected animals is not feasible, prevention of human infection is primarily based on raising awareness, food-safety measures, occupational hygiene and laboratory safety.

Pasteurization of milk for direct consumption and for creating derivatives such as cheese is an important step to preventing transmission from animals to humans. Education campaigns about avoiding unpasteurized milk products can be effective, as well as policies on its sale.

In agricultural work and meat-processing, protective barriers and correct handling and disposal of afterbirths, animal carcasses and internal organs is an important prevention strategy. 

 

Treatment and care

Brucellosis typically causes flu-like symptoms, including fever, weakness, malaise and weight loss. However, the disease may present in many atypical forms. In many patients the symptoms are mild and, therefore, the diagnosis may not be considered. The incubation period of the disease can be highly variable, ranging from 1 week to 2 months, but usually 2–4 weeks.

Treatment options include doxycycline 100 mg twice a day for 45 days, plus streptomycin 1 g daily for 15 days. The main alternative therapy is doxycycline at 100 mg, twice a day for 45 days, plus rifampicin at 15mg/kg/day (600-900mg) for 45 days. Experience suggests that streptomycin may be substituted with gentamicin 5mg/kg/daily for 7–10 days, but no study directly comparing the two regimes is currently available. The optimal treatment for pregnant women, neonates and children under 8 is not yet determined; for children, options include trimethoprim/sulfamethoxazole (co-trimoxazole) combined with an aminoglycoside (streptomycin, gentamycin) or rifampicin.

WHO response

WHO provides technical advice to member states through provision of standards, information and guidance for the management of brucellosis in humans and animals. The Organization works to support the coordination and sharing of information between the public health and animal health sectors. In collaboration with the Food and Agricultural Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE) and the Mediterranean Zoonoses Control Programme (MZCP), WHO supports countries in the prevention and management of the disease through the Global Early Warning System for Major Animal Diseases (GLEWS).  

---

 

Surveillance | Brucellosis | CDC

• Case Definition
• Historic CDC Surveillance Data
• Case Reporting
• Case Notification
• Data Submission

Disease surveillance is a cornerstone of public health practice, enabling early detection, rapid characterization, and efficient response to public health threats like brucellosis. Healthcare providers and public health practitioners are key partners in effective brucellosis surveillance.

Brucellosis Case Definition

The brucellosis surveillance case definition, available at the National Notifiable Diseases Surveillance System (NNDSS) site, provides a set of uniform criteria used to define the disease for public health surveillance. This definition enables public health officials to classify and count cases consistently across jurisdictions.

Historic CDC Surveillance Data

CDC maintains brucellosis surveillance data that are published weekly and annually. These data are available in the NNDSS notifiable infectious disease data tables data tables.

Case Reporting

Brucellosis is a reportable condition in all states and territories. Brucellosis cases must be reported to jurisdictions when identified by a healthcare provider, hospital, or laboratory. Specific reporting requirements – including who must report, how to report, and timing of report – may vary by jurisdiction.

Case Notification

Brucellosis is a nationally notifiable condition (NNC). In 2009, the Council of State and Territorial Epidemiologists (CSTE)external icon developed criteria pdf icon[PDF – 44 KB] for timeliness of NNC case notifications. CSTE requests the following notifications pdf icon[PDF – 13 KB]external icon for confirmed or probable brucellosis cases, dependent on the situation:

Immediate, Urgent: Notification within 24 hours

• Notification criteria: In the event of multiple brucellosis cases, temporally or spatially clustered.
• What to do: The state/territorial epidemiologist (or delegate) should call the CDC Emergency Operations Center (EOC) within 24 hours of knowing the notification criteria are met.
• A CDC subject matter expert (SME) will call back within 4 hours and send written or email confirmation that the case notification was received by CDC.
• Electronic transmission to NNDSS should be completed by the next regularly scheduled transmission cycle (see Data Submission below).
  • Changes in case classification should also be submitted by the next regularly scheduled transmission cycle.

Following immediate, urgent notification:

• For subsequent epidemiologically linked cases: The state/territorial epidemiologist (or delegate) should directly notify the CDC staff who responded to the initial notification, rather than contacting the CDC EOC.
• If a patient is determined to meet case classification criteria during a discussion with CDC, additional notification to the CDC EOC is not needed.

Standard: Notification by electronic transmission

• Notification criteria: In the event of brucellosis cases that are NOT temporally or spatially clustered.
• Electronic transmission to NNDSS should be completed by the next regularly scheduled transmission cycle (see Data Submission).
  • Changes in case classification should also be submitted by the next regularly scheduled transmission cycle.

Data Submission

National-level monitoring of notifiable conditions helps protect the health of the nation. Information from surveillance notifications shared by health departments can be used to better understand disease occurrence, impacted populations, and appropriate prevention and response strategies.

If a patient meets probable or confirmed case criteria, CSTE requests that general information about the patient and disease be submitted to NNDSS using NETSS messages or the generic message mapping guide. For timeliness of electronic reporting, see Case Notification, above.

At this time, additional disease-specific (extended) data for brucellosis cases can be shared separately through the following channels:

• Brucellosis case report form (CRF)

The case report form is available in English as a fillable PDF form that can be completed electronically or can be printed and completed by hand. Completed forms can be emailed, faxed, or mailed to CDC.

Brucellosis Case Report Form pdf icon[PDF – 1086 KB, Print and Fillable PDF]

• Bacterial Special Pathogens Branch (BSPB) DCIPHER Portal

DCIPHER is a web-based data integration platform that is used by several CDC programs. CDC is now also using this platform for brucellosis surveillance, linking case data to CDC laboratory and NNDSS data.

DCIPHER features fillable forms, and point-and-click visualization and tabulation tools. These tools can be used by CDC and jurisdictions to rapidly aggregate and visualize case data, share visualizations and simple analyses, and link case data with other data sources to gain regional or national perspectives on outbreaks, other public health events, and surveillance.

Access to the BSPB DCIPHER portal is granted via SAMS credentialing. Options for data submission using DCIPHER include:

1. Direct entry into a web-based form, similar to the existing CRFs
2. Submission of a data extract from a jurisdictional surveillance system as a CSV file. Submitters can upload the CSV file directly into DCIPHER, via a SAMS folder, or send using another secure method

Jurisdictions may benefit from using the visualization and tabulation tools within DCIPHER, and can access the BSPB DCIPHER portal regardless of which method they choose to share disease-specific surveillance data.

To request DCIPHER access, for more information about the system, or if there are other surveillance-related questions, contact BSPB at [email protected].

Brucellosis: symptoms, diagnosis, treatment

In contact with animals or with thermally unprocessed products of animal origin, there is a risk of infection with brucellosis. This infectious disease affects many human organs and systems and easily becomes chronic with frequent relapses.

General information about infection

The causative agent of brucellosis is the bacterium Brucella, the main reservoir for which are domestic and wild animals and birds. Human infection occurs through contact with an infected animal. Ways of transmission of brucellosis – small wounds on the skin or mucous membranes, the digestive tract when eating animal products, the respiratory tract when inhaling air with infected dust.

Human infection is possible only from an animal. The existence of tick-borne brucellosis has not been proven – so far not a single case of transmission of this infection through tick bites has been recorded.

Brucella can be found not only in the body of animals, but also on their fur, in milk and even in frozen meat, as well as in the soil, where they enter with the feces of animals. The bacterium is excellently adapted to adverse conditions, remaining viable at low temperatures and in the absence of moisture from one and a half months to six months. However, it dies within half an hour when heated to 60 ° C, and when boiled, it is destroyed instantly. Therefore, eating animal products after heat treatment is completely safe.

Symptoms of disease

Between the penetration of bacteria into the body and the appearance of the first signs of brucellosis, at least a week passes, sometimes the incubation period lasts up to two months, but its most frequent duration is two weeks. Symptoms develop gradually and include:

• severe increase in body temperature up to 38-39°C, accompanied by chills and fever;
• increased sweating, especially during nocturnal sleep;
• a sharp decline in strength, a feeling of weakness;
• the appearance of pain in the joints of the limbs, tingling in different parts of the body.

The listed symptoms of brucellosis can be undulating in nature: gradually increase and intensify, then decrease and disappear for a while. The disease is systemic in nature and affects the human musculoskeletal system, nervous system and reproductive organs, provoking the development of concomitant ailments.

Pathogenesis

The development of brucellosis in humans goes through several stages.

1. Lymphogenic – bacteria penetrate the lymphatic system and occupy the lymph nodes with the lymph flow, without leading to their enlargement.
2. Hematogenous drift – having penetrated into the circulatory system, bacteria release toxins that act on nerve fibers through the blood.
3. Acute brucellosis – with the bloodstream, bacteria penetrate into the tissues of various organs, forming secondary foci of infection in the form of granulomas, and sometimes inflammatory abscesses.
4. Exofocal contamination – new foci of infection appear, an allergic reaction to unfavorable factors develops in the body, chronic brucellosis is formed, which lasts for several years with numerous relapses;
5. Residual effects – the final stage of the disease, which is characterized by deformation of bone tissue and joints, allergic manifestations and disorders of the nervous system, which are usually irreversible.

After the end of the disease, the patient develops temporary immunity, the duration of which is from six months to five years, after which the person can again become infected.

Infection detection

The technique for diagnosing brucellosis is well developed and is based on laboratory tests aimed at identifying the pathogen, which include:

• general blood test;
• biochemical blood test;
• bakposev biomaterials;
• serological examination;
• blood test for detection of antigens;
• PCR test for Brucella DNA;
• Brucella antibody testing.

In addition, to detect pathological changes in the patient’s body, ultrasound and x-ray studies of damaged organs may be needed.

How to treat brucellosis

Antibiotics are prescribed for the treatment of acute brucellosis. When the disease becomes chronic, these drugs cease to be effective, immunoglobulins with anti-brucellosis antibodies and vaccines with killed bacteria have a much more pronounced effect. Supportive and strengthening therapy is important – ultraviolet irradiation sessions, taking vitamin complexes, etc. When an allergic reaction occurs, antiallergic drugs are prescribed. During the recovery period, a visit to balneological resorts with radon and sulfur-radon waters is shown.

How to prevent illness

Unfortunately, the development of an effective long-acting vaccine that prevents the development of infection in humans has proved impossible. However, subject to simple measures to prevent brucellosis, it is quite possible to avoid the disease. For this you need:

• boil or pasteurize milk before eating;
• avoid dry-cured meat products;
• observe hygiene rules, wash hands after contact with animals, agricultural workers wear protective gloves;
• to vaccinate livestock, since the brucellosis vaccine for animals has long been developed, and in countries that practice blanket vaccination of livestock, this disease has practically disappeared.

In case of contact with an infected animal, it is necessary to monitor the state of health for at least six months, periodically taking tests for the presence of bacteria in biomaterials.

Frequently Asked Questions

Is brucellosis transmitted from person to person?

Medicine excludes the possibility of transferring brucellosis from person to person, since the bacterium cannot enter the body by airborne droplets or by contact. There are some data on the ways of brucellosis infection of infants through mother’s milk and fetus from a pregnant mother.

Why is brucellosis dangerous for humans?

Brucellosis is a severe infection, the main danger of which is the negative impact of the toxin released by bacteria on human organs and systems. The most common complications are endocarditis, the main cause of death from this infection, arthritis leading to deformity of the joints and bones, inflammation of the reproductive organs, liver and spleen, and infections of the nervous system.

Is there a cure for brucellosis today?

Modern medicine has the ability to completely cure patients with brucellosis, but only if the patient consults a doctor. Timely detection of the disease allows you to provide all the necessary assistance at an early stage and prevent the development of serious complications.

Brucellosis: symptoms, diagnosis, treatment

Bang and Traum’s disease, Bruce’s septicemia, Mediterranean, goat, Crimean fever – all these intricate terms hide one socially significant infectious and allergic disease – brucellosis. How can you get infected, what are the symptoms of this infection, how to treat it? The answers to these and other questions about brucellosis are in our article.

A bit of history

The first information about brucellosis appeared in the middle of the 19th century thanks to the English military surgeon J. Marston. He studied sick soldiers on the island of Malta and drew attention to the fact that they all ate goat’s milk. A little later, in 1887, British Army physician David Bruce isolated the brucellosis pathogen from the spleen of five English soldiers who died of a fever. Initially, it was named the Maltese micrococcus, and later renamed in honor of the discoverer scientist in brucella.

The connection of the disease with animals was finally established in the course of research by D. Bruce and other scientists already at the beginning of the 20th century. By this time, three types of Brucella had been isolated. Currently, six types of the causative agent of brucellosis are known, four of which are extremely dangerous for humans.

Features of the causative agent of brucellosis

Microorganisms of the genus Brucella are gram-negative bacteria that are resistant to low temperatures, but do not “like” high temperatures at all: when boiled, brucella dies instantly, and when heated to 60 degrees Celsius – within half an hour. Serious enemies of bacteria are direct sunlight and disinfectants.

Despite their apparent vulnerability, bacteria have qualities that allow them to parasitize the body for a long time, depleting it. One of these qualities is the ability to transform into specific L- and S-forms under the influence of antibiotics and immune cells. This feature leads to a chronic process with the subsequent development of complications.

Brucella secrete substances that inhibit the activity of macrophages (cells-“defenders” that are involved in the capture and destruction of pathogenic microorganisms). This creates conditions for parasitizing Brucella inside the cells of the immune system. Endotoxin, released during the death and destruction of these bacteria, causes severe intoxication of the body and leads to metabolic disorders in it.

How do you get brucellosis?

The main distributors of brucellosis are goats, sheep, pigs, cows, although all types of domestic animals and birds are susceptible to the disease. Usually, infection occurs when eating dairy products and meat that have not undergone sufficient heat treatment.

The contact route of penetration of the pathogen into the human body through damaged skin or mucous membranes is not excluded – when interacting with the hair, bedding, food and water of an infected animal. This explains the high incidence of brucellosis among livestock workers (milkmaids, shepherds, veterinarians, livestock specialists) and people involved in the processing of livestock products.

Brucellosis can also be contracted by aerogenic means, if you comb out the hair from a sick animal or cut it.

A sick person does not pose a danger to others. The exception is infection of the fetus from an infected mother.

After pathogens enter the body, they are captured by macrophages, multiply in them and penetrate into the lymph nodes. From there, the bacteria spread throughout the body through the blood and lymph.

Symptoms of brucellosis

It is possible to assume the presence of the disease by a set of complaints such as excruciating pain in the joints (mainly in the legs) against the background of increased sweating, severe weakness, as well as wave-like fever (with a sharp rise and fall in body temperature).

The spread of the causative agent of brucellosis throughout the body causes systemic damage to almost all organs. Patients have pathologies of the musculoskeletal system in the form of monoarthritis, polyarthritis, osteomyelitis, myalgia. There are inflammatory processes in the heart, lungs, genitourinary system. The defeat of the central nervous system in brucellosis is expressed in the form of meningitis, encephalitis, abscesses in the brain, atrophy of the optic nerve.

Brucellosis is also characterized by lymphadenitis (inflammation of the lymph nodes) and splenomegaly (enlarged spleen).

Diagnosis of brucellosis

Collection of complaints and anamnesis, examination is the first stage in the diagnosis of the infectious process. It is important to obtain information about whether the patient belongs to a risk group.

Isolation of bacteria is required to confirm the diagnosis. This is possible when a person has a blood test for brucellosis. The reaction of Coombs, Wright, RSK (complement fixation reaction), PCR diagnostics – these research methods make it possible to identify all forms of bacteria.

One of the easiest ways to diagnose an infection is the Berne skin test.

How and where is brucellosis treated?

The treatment of brucellosis consists of the following basic principles:

• measures aimed at combating the pathogen;
• elimination of pain syndrome;
• combating complications;
• rehabilitation.

Self-treatment for brucellosis is unacceptable. In the acute phase of the infectious process and with the development of complications, inpatient treatment is necessary. The selection of antibacterial and antiallergic drugs, physiotherapeutic procedures is carried out by the attending physician, depending on the phase and severity of the process, as well as the existing complications.

How to prevent infection with brucellosis?

To prevent infection, doctors recommend following a few simple principles:

• follow the rules of personal hygiene, especially when it comes to contact with domestic and farm animals;
• thoroughly wash and cook animal products;
• do not ignore the symptoms that appear and seek medical attention immediately.